-
Analysis of a persistent viral shedding patient infected with SARS-CoV-2 by RT-qPCR, FilmArray Respiratory Panel v2.1, and antigen detection.
Hirotsu Y, Maejima M, Shibusawa M, Amemiya K, Nagakubo Y, Hosaka K, Sueki H, Hayakawa M, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M.
J Infect Chemother. 2021;27(2):406-409.
- Discrepancy Between Clinical Diagnosis and Whole-exome Sequencing-based Clonality Analysis of Synchronous Multiple Oral Cancers.
Nishii N, Hirotsu Y, Koida N, Takahashi Y, Takagawa Y, Amemiya K, Oyama T, Mochizuki H, Furusawa-Nishii E, Harada H, Omata M.
Anticancer Res. 2021 Feb;41(2):1035-1040.
- Prospective Study of 1,308 Nasopharyngeal Swabs from 1,033 Patients using the LUMIPULSE SARS-CoV-2 Antigen Test: Comparison with RT-qPCR.
Hirotsu Y, Maejima M, Shibusawa M, Amemiya K, Nagakubo Y, Hosaka K, Sueki H, Hayakawa M, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M.
Int J Infect Dis. 2021 in press
- The dynamic change of antibody index against Covid-19 is a powerful diagnostic tool for the early phase of the infection and salvage PCR assay errors.
Omata M, Hirotsu Y, Sugiura H, Maejima M, Nagakubo Y, Amemiya K, Hayakawa M, Tsutsui T, Kakizaki Y, Mochizuki H, Miyashita Y.
J Microbiol Immunol Infect. 2021:S1684-1182
- Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan.
Hirotsu Y, Omata M.
J Infect. 2021 Jun;82(6):276-316.
- Actionable driver DNA variants and fusion genes can be detected in archived cytological specimens with the Oncomine Dx Target Test Multi-CDx system in lung cancer.
Amemiya K, Hirotsu Y, Nagakubo Y, Mochizuki H, Higuchi R, Tsutsui T, Kakizaki Y, Miyashita Y, Oyama T, Omata M.
Cancer Cytopathol. 2021 in press.
- Streptococcus australis and Ralstonia pickettii as Major Microbiota in Mesotheliomas.
Higuchi R, Goto T, Hirotsu Y, Otake S, Oyama T, Amemiya K, Mochizuki H, Omata M.
J Pers Med. 2021;11(4):297.
- Comprehensive mutational analysis of background mucosa in patients with Lugol-voiding lesions.
Akizue N, Okimoto K, Arai M, Hirotsu Y, Amemiya K, Oura H, Kaneko T, Tokunaga M, Ishikawa K, Ohta Y, Taida T, Saito K, Maruoka D, Matsumura T, Nakagawa T, Nishimura M, Chiba T, Matsushita K, Mochizuki H, Yokosuka O, Omata M, Kato N.
Cancer Med. 2021 Jun;10(11):3545-3555.
- Detection of actionable mutations in archived cytological bile specimens.
Ohyama H, Hirotsu Y, Amemiya K, Oyama T, Iimuro Y, Kojima Y, Mikata R, Mochizuki H, Kato N, Omata M.
J Hepatobiliary Pancreat Sci. 2021;28(10):837-847
- Comparison of Roche and Lumipulse quantitative SARS-CoV-2 antigen test performance using automated systems for the diagnosis of COVID-19.
Hirotsu Y, Sugiura H, Maejima M, Hayakawa M, Mochizuki H, Tsutsui T, Kakizaki Y, Miyashita Y, Omata M.
Int J Infect Dis. 2021;108:263-269.
- Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan.
Hirotsu Y, Omata M.
PLoS Pathog. 2021;17(6):e1009619
- EML4-ALK fusion variant.3 and co-occurrent PIK3CA E542K mutation exhibiting primary resistance to three generations of ALK inhibitors.
Kunimasa K, Hirotsu Y, Kukita Y, Ueda Y, Sato Y, Kimura M, Otsuka T, Hamamoto Y, Tamiya M, Inoue T, Kawamura T, Nishino K, Amemiya K, Goto T, Mochizuki H, Honma K, Omata M, Kumagai T.
Cancer Genet. 2021;256-257:131-135.
- Genetic profiles of Barrett’s esophagus and esophageal adenocarcinoma in Japanese patients.
Tokunaga M, Okimoto K, Akizue N, Ishikawa K, Hirotsu Y, Amemiya K, Ota M, Matsusaka K, Nishimura M, Matsushita K, Ishikawa T, Nagashima A, Shiratori W, Kaneko T, Oura H, Kanayama K, Ohta Y, Taida T, Saito K, Matsumura T, Chiba T, Mochizuki H, Arai M, Kato J, Ikeda JI, Omata M, Kato N.
Sci Rep. 2021;11(1):17671.
- Robust Antibody Responses to the BNT162b2 mRNA Vaccine Occur Within a Week After the First Dose in Previously Infected Individuals and After the Second Dose in Uninfected Individuals.
Hirotsu Y, Amemiya K, Sugiura H, Shinohara M, Takatori M, Mochizuki H, Omata M.
Front Immunol. 2021;12:722766.
- SARS-CoV-2 B.1.1.7 lineage rapidly spreads and replaces R.1 lineage in Japan: Serial and stationary observation in a community.
Hirotsu Y, Omata M.
Infect Genet Evol. 2021;95:105088.
- Sphingomonas and Phenylobacterium as Major Microbiota in Thymic Epithelial Tumors.
Higuchi R, Goto T, Hirotsu Y, Otake S, Oyama T, Amemiya K, Ohyama H, Mochizuki H, Omata M.
J Pers Med. 2021;11(11):1092.
- The Use of Electronic Medical Records-Based Big-Data Informatics to Describe ALT Elevations Higher than 1000 IU/L in Patients with or without Hepatitis B Virus Infection.
Amano H, Kanda T, Mochizuki H, Kojima Y, Suzuki Y, Hosoda K, Ashizawa H, Miura Y, Tsunoda S, Hirotsu Y, Ohyama H, Kato N, Moriyama M, Obi S, Omata M.
Viruses. 2021;13(11):2216.
- Discrimination Between Primary Lung Cancer and Lung Metastases by Genomic Profiling.
Higuchi R, Goto T, Nakagomi T, Hirotsu Y, Oyama T, Amemiya K, Mochizuki H, Omata M.
JTO Clin Res Rep. 2021;2(12):100255.
- Lung Cancer Surgery With Persistent COVID-19 Infection.
Nakagomi T, Goto T,Hirotsu Y, Higuchi R, Tsutsui T, Amemiya K, Oyama T, Mochizuki H, Omata M.
Ann Thorac Surg. 2022 Aug;114(2):e79-e81.
